IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Dcvc Opportunity Fund II GP, LLC

Q4 2025 Holdings

Filed 2026-02-17 | 2 holdings | $16.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Recursion Pharmaceuticals, Inc.(RXRX)CL A75629V104$16.2M3,951,14197.4%
IonQ, Inc.(IONQ)CL A46222L108$427.2K9,5212.6%